Capital Senior Living Corp (CSU) Fundamental Analysis & Valuation
NYSE:CSU
Current stock price
33.54
-0.72 (-2.09%)
Last:
This CSU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CSU Profitability Analysis
1.1 Basic Checks
- CSU had negative earnings in the past year.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.75% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CSU does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | -49.97% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. CSU Health Analysis
2.1 Basic Checks
- CSU has about the same amout of shares outstanding than it did 1 year ago.
- CSU has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -1.29, we must say that CSU is in the distress zone and has some risk of bankruptcy.
- A Debt/Equity ratio of -2.98 indicates that CSU is not too dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | -2.98 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.29 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- CSU has a Current Ratio of 0.11. This is a bad value and indicates that CSU is not financially healthy enough and could expect problems in meeting its short term obligations.
- A Quick Ratio of 0.11 indicates that CSU may have some problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 |
3. CSU Growth Analysis
3.1 Past
- CSU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -169.26%.
- Looking at the last year, CSU shows a very negative growth in Revenue. The Revenue has decreased by -30.87% in the last year.
- CSU shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.41% yearly.
EPS 1Y (TTM)-169.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%472.86%
Revenue 1Y (TTM)-30.87%
Revenue growth 3Y-6.32%
Revenue growth 5Y-1.41%
Sales Q2Q%-43.31%
3.2 Future
- CSU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.95% yearly.
- Based on estimates for the next years, CSU will show a decrease in Revenue. The Revenue will decrease by -3.59% on average per year.
EPS Next Y127.22%
EPS Next 2Y39.76%
EPS Next 3Y25.31%
EPS Next 5Y13.95%
Revenue Next Year-39.6%
Revenue Next 2Y-18.7%
Revenue Next 3Y-10.67%
Revenue Next 5Y-3.59%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. CSU Valuation Analysis
4.1 Price/Earnings Ratio
- CSU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year CSU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 38.81 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CSU's earnings are expected to grow with 25.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.76%
EPS Next 3Y25.31%
5. CSU Dividend Analysis
5.1 Amount
- No dividends for CSU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CSU Fundamentals: All Metrics, Ratios and Statistics
NYSE:CSU (11/12/2021, 8:52:54 PM)
33.54
-0.72 (-2.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners127.24%
Ins Owner Change0%
Market Cap70.07M
Revenue(TTM)295.44M
Net Income(TTM)-147.62M
Analysts42.5
Price Target23.46 (-30.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.24 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 38.81 |
EPS(TTM)-72.7
EYN/A
EPS(NY)-5.77
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS141.43
BVpS-91.27
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -21.75% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | -49.97% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | -2.98 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.11 | ||
| Quick Ratio | 0.11 | ||
| Altman-Z | -1.29 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%472.86%
EPS Next Y127.22%
EPS Next 2Y39.76%
EPS Next 3Y25.31%
EPS Next 5Y13.95%
Revenue 1Y (TTM)-30.87%
Revenue growth 3Y-6.32%
Revenue growth 5Y-1.41%
Sales Q2Q%-43.31%
Revenue Next Year-39.6%
Revenue Next 2Y-18.7%
Revenue Next 3Y-10.67%
Revenue Next 5Y-3.59%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
Capital Senior Living Corp / CSU Fundamental Analysis FAQ
What is the fundamental rating for CSU stock?
ChartMill assigns a fundamental rating of 1 / 10 to CSU.
What is the valuation status of Capital Senior Living Corp (CSU) stock?
ChartMill assigns a valuation rating of 0 / 10 to Capital Senior Living Corp (CSU). This can be considered as Overvalued.
How profitable is Capital Senior Living Corp (CSU) stock?
Capital Senior Living Corp (CSU) has a profitability rating of 1 / 10.
How financially healthy is Capital Senior Living Corp?
The financial health rating of Capital Senior Living Corp (CSU) is 2 / 10.
What is the expected EPS growth for Capital Senior Living Corp (CSU) stock?
The Earnings per Share (EPS) of Capital Senior Living Corp (CSU) is expected to grow by 127.22% in the next year.